Vanda Pharmaceuticals
VNDA
#8548
Rank
C$0.39 B
Marketcap
C$6.51
Share price
0.88%
Change (1 day)
-14.64%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -C$0.26 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2025 the company made an earning of -C$0.22 Billion a decrease over its 2024 earnings that were of -C$57.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.26 Billion20.33%
2025 -C$0.22 Billion271.79%
2024 -C$57.96 Million191.43%
2023 -C$19.89 Million-320.45%
2022 C$9.02 M-84.99%
2021 C$60.1 M54.8%
2020 C$38.82 M19.42%
2019 C$32.51 M4.93%
2018 C$30.98 M-228.6%
2017 -C$24.1 Million-8.98%
2016 -C$26.48 Million-53.79%
2015 -C$57.28 Million-30.18%
2014 -C$82.04 Million173.08%
2013 -C$30.05 Million-25.33%
2012 -C$40.24 Million163.61%
2011 -C$15.27 Million-221.15%
2010 C$12.59 M-124.53%
2009 -C$51.37 Million-29.44%
2008 -C$72.79 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$93.67 Million170.55%
2005 -C$34.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.35 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.12 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.84 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$47.88 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.96 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.97 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$4 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA